We applaud the Sept. 2 op-ed by Rep. Karen Bass (D-Calif.) regarding the importance of promoting diversity in the clinical trial patient population [“Vaccine trials’ lack of diversity threatens their validity”]. It’s the right thing to do morally, and it will strengthen trial success rates by enhancing data and better mirroring the people our drugs […]
Before the coronavirus pandemic, clinical research sites were already operating on low margins, and often faced tight financial constraints and understaffed workforces. According to a survey by Society for Clinical Research Sites (SCRS) released in early April, 59% of sites in 2019 reported that they had three months or less of operating cash. […]
Clinical trial managers need to focus training on skills, not systems or roles, to bring much-needed improvement to clinical trial performance. “I love the idea of being able to train people, and I think the direction of that training is moving from being system- and role-based to being skill-based,” said David Burrow, director of the […]
Raise your hand if you:
Chances are you’re in the minority if your hand shot up. This is […]
"Sites are overwhelmed with too many solutions and ballooning login credentials," said Jim Kremidas, executive director, ACRP. "Instead of engaging with patients, an inordinate amount of time is spent learning new systems, completing redundant required training and reentering the same data multiple times. Simultaneously, pharmaceutical companies and CROs are left with a fragmented ecosystem of software, hardware, […]
